STAT3 and neoplasm: A deeper understanding of the interplay between the differentially phosphorylated forms of STAT3 and their relative sub-cellular distribution under specific pathological conditions and in different tumor types may help designing function-specific inhibitors that may be tested as targeted therapeutic approaches.